Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles

被引:214
作者
Ebner, T.
Sommergruber, M.
Moser, M.
Shebl, O.
Schreier-Lechner, E.
Tews, G.
机构
[1] Landes Frauen & Kinderklin, IVF Unit, A-4020 Linz, Austria
[2] Landes Frauen & Kinderklin, Dept Lab Med, Linz, Austria
关键词
AMH; central granulation; cycle cancellation; FSH; oocyte quality;
D O I
10.1093/humrep/del127
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Serum anti-Mullerian hormone (AMH) levels provide a powerful means for predicting ovarian response, which is reflected not only by the size of the primordial follicle pool but also by the quality of the oocytes. Considering a mutual interdependence between AMH-expressing somatic cells and gametes, this prospective morphological study was set up to evaluate whether extreme AMH levels represent diminished oocyte quality and developmental incompetence. METHODS: A total of 141 consecutive ICSI patients were subdivided into three groups using the 25th and 75th percentiles of the serum AMH levels (cycle day 3). In these three groups, morphology of all oocytes and fertilization rate, embryo quality and blastocyst formation were evaluated, and FSH, LH and estradiol (E-2) levels were also measured. RESULTS: Cycle cancellation rate was correlated with AMH levels (P < 0.05). AMH groups 1 (< 1.66 ng/ml) and 3 (> 4.52 ng/ml) showed oocytes of lower quality [dark central granulation, aggregation of smooth endoplasmic reticulum (sER)] compared with the median group 2 (1.66-4.52 ng/ml). Basal serum FSH did not allow for adequate prognosis in terms of gamete appearance. Fertilization and further cleavage up to blastocyst stage was not affected by AMH levels. CONCLUSIONS: AMH seems to be superior to FSH in predicting both oocyte number and quality.
引用
收藏
页码:2022 / 2026
页数:5
相关论文
共 34 条
[21]   The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes [J].
Otsuki, J ;
Okada, A ;
Morimoto, K ;
Nagai, Y ;
Kubo, H .
HUMAN REPRODUCTION, 2004, 19 (07) :1591-1597
[22]   Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment [J].
Peñarrubia, J ;
Fábregues, F ;
Manau, D ;
Creus, M ;
Casals, G ;
Casamitjana, R ;
Carmona, F ;
Vanrell, JA ;
Balasch, J .
HUMAN REPRODUCTION, 2005, 20 (04) :915-922
[23]  
PEPINSKY RB, 1988, J BIOL CHEM, V263, P18961
[24]   Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest [J].
Pigny, P ;
Merlen, E ;
Robert, Y ;
Cortet-Rudelli, C ;
Decanter, C ;
Jonard, S ;
Dewailly, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5957-5962
[25]   Expression of anti-Mullerian hormone during normal and pathological gonadal development:: Association with differentiation of Sertoli and granulosa cells [J].
Rajpert-De Meyts, E ;
Jorgensen, N ;
Græm, N ;
Müller, J ;
Cate, RL ;
Skakkebæk, NE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3836-3844
[26]   Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles [J].
Seifer, DB ;
MacLaughlin, DT ;
Christian, BP ;
Feng, B ;
Shelden, RM .
FERTILITY AND STERILITY, 2002, 77 (03) :468-471
[27]   Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology [J].
Silberstein, T ;
MacLaughlin, DT ;
Shai, I ;
Trimarchi, JR ;
Lambert-Messerlian, G ;
Seifer, DB ;
Keefe, DL ;
Blazar, AS .
HUMAN REPRODUCTION, 2006, 21 (01) :159-163
[28]   Mullerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications [J].
Teixeira, J ;
Maheswaran, S ;
Donahoe, PK .
ENDOCRINE REVIEWS, 2001, 22 (05) :657-674
[29]   Anti-mullerian hormone as a marker of ovarian reserve [J].
Tremellen, KP ;
Kolo, M ;
Gilmore, A ;
Lekamge, DN .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2005, 45 (01) :20-24
[30]   Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve [J].
van Rooij, IAJ ;
Broekmans, FJM ;
te Velde, ER ;
Fauser, BCJM ;
Bancsi, LFJMM ;
de Jong, FH ;
Themmen, APN .
HUMAN REPRODUCTION, 2002, 17 (12) :3065-3071